Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility

Drug Development and Industrial Pharmacy

Volumn 40, Issue 1, 2014, Pages 102-109

  Bolko, Katarina ^a   Zvonar, Alenka ^a   Gašperlin, Mirjana ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Castor oil; Diglyceride; Lipid based delivery; Long chain lipid; Medium chain lipid; Microemulsion; Phase diagram; Self microemulsifying

Indexed keywords

CASTOR OIL; EXCIPIENT; GELATIN; LIPID; RESVERATROL;

ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MIXTURE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; EXCIPIENT COMPATIBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MICROEMULSION; SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM; VISCOSITY;

ANTIOXIDANTS; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; DRUG STORAGE; EMULSIONS; LIPIDS; PARTICLE SIZE; PHASE TRANSITION; SOLUBILITY; STILBENES; SURFACE-ACTIVE AGENTS; TIME FACTORS; VISCOSITY;

EID: 84890497517     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.749888     Document Type: Article

References (34)

1. King RE, Bomser JA, Min DB. Bioactivity of resveratrol. Compr Rev Food Sci F 2006;5:65-70.
2. Signorelli P, Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 2005;16:449-66.
3. Henry C, Vitrac X, Decendit A, et al. Cellular uptake and efflux of trans-piceid and its agylcone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells. J Agric Food Chem 2005;53:798-803.
4. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5:493-506.
5. Sasaki S. Alcohol and its relation to all-cause and cardiovascular mortality. Acta Cardiol 2000;55:151-6.
6. Kristl J, Teskac? K, Caddeo C, et al. Improvements of cellular stress response on resveratrol in liposomes. Eur J Pharm Biopharm 2009;73:253-9.
7. Teskac? K, Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm 2010;390:61-9.
8. Santos AC, Veiga F, Ribeiro AJ. New delivery systems to improve the bioavailability of resveratrol. Expert Opin Drug Deliv 2011;8:973-90.
9. Amri A, Chaumeil JC, Sfar S, Charrueau C. Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release 2012;158:182-93.
10. Delmas D, Aires V, Limagne E, et al. Transport, stability, and biological activity of resveratrol. Ann NY Acad Sci 2011;1215:48-59.
11. Li Y, Shin YG, Yu C, et al. Increasing the throughput and productivity of Caco-2 cell permeability using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. Combin Chem High Throughput Screen 2003;6:757-67.
12. Filip V, Plockova M, S ? midrkal J, et al. Resveratrol and its antioxidant and antimicrobial effectiveness. Food Chem 2003;83:585-93.
13. Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci 2011;1215:9-15.
14. Constatinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 1995;12:1561-72.
15. Zhao L, Zhang L, Meng L, et al. Design and evaluation of a selfmicroemulsifying drug delivery system for apigenin. Drug Dev Ind Pharm 2012; early online:1-8.
16. Zhu J, Tang D, Feng L, et al. Development of selfmicroemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochloride. Drug Dev Ind Pharm; early online:1-8.
17. Kang MJ, Kim HS, Jeon HS, et al. In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in selfmicroemulsifying drug delivery system. Drug Dev Ind Pharm 2012;38:587-96.
18. Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007;6:231-48.
19. Zvonar A, Berginc K, Kristl A, Gasperlin M. Microencapsulation of self-microemulsifying system: improving solubility and permeability of furosemide. Int J Pharm 2010;388:151-8.
20. Bagwe RP, Kanicky JR, Palla BJ, et al. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit Rev Ther Drug Carrier Syst 2001;18:77-140.
21. Humberstone AJ, Charman, WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997;25:103-28.
22. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89-121.
23. Mei X, Etzler FM, Wang Z. Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules. Int J Pharm 2006;324:128-35.
24. Rahman MA, Hussain A, Hussain MS, et al. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev Ind Pharm 2012; early online:1-19.
25. Caddeo C, Teskac K, Sinico C, Kristl J. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm 2008;363:183-91.
26. Warisnoicharoen W, Lansley AB, Lawrence MJ. Nonionic oil-in-water microemulsions: the effect of oil type on phase behavior. Int J Pharm 2000;198:7-27.
27. Bandivadeka MM, Pancholi SS, Kaul-Ghanekar R, et al. Selfmicroemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly watersoluble drug. Drug Dev Ind Pharm 2012;38:883-92.
28. Constantinides PP, Scalart J. Formulation and physical characterization of water-in-oil microemulsions containing long- versus medium-chain glycerides. Int J Pharm 1997;158:57-68.
29. Prajapati HN, Dalrymple DM, Serajuddin ATM. A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/ water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development. Pharm Res 2012;1:285-305.
30. Stegemann S, Bornem C. Hard gelatin capsules today - and tomorrow. Capsugel Library 1999;1:1-23.
31. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006;29:278-87.
32. Pouton CW. Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int J Pharm 1985;27:335-48.
33. Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Del Rev 2008;60:673-91.
34. Lee CW, Yen FL, Huang HW, et al. Resveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and anti-inflammatory pathways. J Agric Food Chem 2012;60:4662-71.